Inflame Applian. Q4 FY26 Results & Concall Highlights: Revenue, Margins & Order Book
Published 25 Aug 2026 | Consumer Durables | Market Cap: ₹164 Cr
Targeting 50% growth in sales revenue for FY27, continuing month-on-month improvements. Targeting 50% revenue growth for FY27, with a revenue aim of INR400+ crores by FY28.
From Inflame Applian.'s Q4 FY26 earnings-call transcript · updated 25 Aug 2026.
Price
₹242
Market Cap
₹164 Cr
P/E Ratio
28.5
Revenue Rank
Margin Rank
How does Inflame Applian. rank in Consumer Durables?
Compare Inflame Applian. against every Consumer Durables company this quarter on revenue, margins and earnings-call signals.
📊 Revenue & Sales Performance
Rank 1- →Targeting 50% growth in sales revenue for FY27, continuing month-on-month improvements.
- →Expect to achieve INR 400 crores+ revenue by FY28 with ramped-up product lines and completed facility expansion.
- →Projected revenue to reach around INR 500 crores in FY28 or FY29.
- →Target of producing 4 lakh chimneys in FY27, up from 2.7 lakh in the previous year, aligning with 50% growth.
- →Gradual ramp-up in manufacturing capacity, especially for built-in refrigerators, wine coolers, ovens, dishwashers, and microwaves by 2027.
- →Increased focus on import substitution, particularly in BLDC motors and electronics, to improve margins and control.
- →Continued market demand recovery expected, supporting sustainable volume and revenue growth.
📈 Profitability & Margins
Rank 3- →Targeting 50% revenue growth for FY27, with a revenue aim of INR400+ crores by FY28.
- →Projected to reach INR500 crores revenue around FY28-FY29 with new product lines and capacity expansions.
- →EBITDA margins expected to increase with volume growth and operational efficiencies despite raw material cost pressures.
- →Margin pressures from raw materials are to be offset by cost efficiency initiatives (AI inspection systems, process improvements).
- →Earnings per share (EPS) grew by 85% in the previous year; further improvement expected with revenue growth.
- →Expansion of BLDC product share to 80% by end of FY26, supporting margins and import substitution efforts.
- →Operating profits and margins anticipated to improve with reduced dependency on imports and better supply chain management.
- →Overall, management is optimistic about sustainable profit and earnings growth driven by increased capacity, new products, and efficiency gains.
🏗️ Capital Expenditure Plans
Yes- →Panchkula Plant Expansion:
- → - INR 8-10 crore capex underway.
- → - One part of the plant completed and operational.
- → - Ground floor to be utilized imminently.
- → - First and second floors under construction, expected ready by mid-August and end-September 2026 respectively.
- →Glass Plant Automation:
- → - Plan for a zero-manpower glass plant with 250% production increase post INR 250-300 crore investment.
- → - Discussions and supplier visits already conducted.
- →Joint Venture & Backward Integration:
- → - Inflame holds 34% in Tricoree Machmatrix Pvt. Ltd.
- → - Focus on electronics, IoT-enabled products, BLDC motor manufacturing.
- → - Setup for backward integration to reduce dependency on Chinese imports.
- → - First phase: BLDC motors.
- → - Second phase: electronics (PCBA, switches).
- → - Future: IoT-enabled smart control solutions.
- →Automation Initiatives:
- → - AI-based visual inspection systems for quality control are being implemented to improve efficiency and reduce manpower costs.
💰 Fundraising & Capital Structure
No information- →There is no immediate confirmation of new fundraising through equity or debt during the call.
- →When asked about increasing equity to move to the Main Board, the management indicated these are forward-looking questions and did not provide a direct answer.
- →They mentioned plans to possibly consider promoters raising their stake after Diwali, suggesting potential equity infusion could be considered in the near future.
- →No concrete plans for debt raising were discussed in the transcript.
- →The primary focus appears to be on organic growth, capacity enhancement, and backward integration through a joint venture for manufacturing BLDC motors and electronics.
- →Any decision on fundraising will be addressed at the "right time" as per management’s comments.
📋 Order Book & Pipeline
Yes- →Orders are typically firm only for one month; longer-term firm orders (2-3 months) are not common.
- →The company closely tracks expected monthly orders from key customers like Hindware, Havells, and KAFF based on market share and demand.
- →Currently, the company has a comfortable order position with more orders than the planned growth rate.
- →Unexecuted orders occur due to component delays or shipping issues but are generally managed efficiently.
- →The order book is healthy, with a good outlook for the next 2-3 months.
- →Recent months have shown growth trending positively with month-on-month improvement.
- →The company expects sustained increased demand, targeting 40-50% growth.
- →Despite geopolitical uncertainties, key customers have resumed strong ordering patterns.
Key Metrics
Revenue
Margin
Capex
Fundraise
Order Book
Frequently Asked Questions
What were Inflame Applian. Q4 FY26 results?
Targeting 50% growth in sales revenue for FY27, continuing month-on-month improvements. Targeting 50% revenue growth for FY27, with a revenue aim of INR400+ crores by FY28.
What is Inflame Applian. share price analysis?
Inflame Applian. currently shows a strong growth signal based on ranking data. The stock trades at a P/E of 28.5 with a market cap of ₹164 Cr. Investors should review the full earnings analysis for detailed insights.
Is Inflame Applian. planning capital expenditure?
Panchkula Plant Expansion: - INR 8-10 crore capex underway. - One part of the plant completed and operational. - Ground floor to be utilized imminently. - First and second floors under construction, expected ready by mid-August and end-September 2026 respectively. - Glass Plant Automation: - Plan for a zero-manpower glass plant with 250% production increase post INR 250-300 crore investment. - Discussions and supplier visits already conducted. - Joint Venture & Backward Integration: - Inflame holds 34% in Tricoree Machmatrix Pvt.
Keep Inflame Applian. on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and concall transcripts. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.